WOUNDGENEX PARTNERS WITH MIMEDX TO LAUNCH PREMIER GRAFT PROGRAM TO WOUND CARE PROVIDERS NATIONWIDE

Tampa, FL – March 16th , 2022, Leading wound care management and clinical services provider, WoundGenex, today announced a strategic partnership with MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX”), a transformational placental biologics company, to launch an exclusive version of WoundGenex’s Premier Graft Program to its clients across the country, providing clinicians access to industry-leading allograft […]